NewsMeter
The July 16, 2026 investor alert from Pomerantz LLP names Larimar Therapeutics, Inc. (NASDAQ: LRMR) as the subject of a formal securities investigation. The New York firm issued the notice via PRNewswire.
No class period or alleged damages figure appears in the published alert. Investor contact Pomerantz LLP identified Danielle Peyton as the designated investor contact.
Shareholders seeking to participate can reach her at newaction@pomlaw.com or 646-581-9980, ext. The alert does not detail the scope of the inquiry or the time period at issue.
Scope of the alert The published alert states no legal theory and names no specific regulatory filing.
Keep reading